// App-Quantinova.ai

: THIOREDOXIN SYSTEM INHIBITORS ARE EFFECTIVE AGAINST B CELL ACUTE LYMPHOBLASTIC LEUKEMIA IN VITRO AND IN VIVO

Researchers

Presenter

  • Klaudyna Fidyt

Principal Investigators

  • Agata Pastorczak

  • Agnieszka Goral

  • Angelika Muchowicz

  • Lukasz Komorowski

  • Julia Cyran

  • Deepali Pal

  • Helen Blair

  • Anna Burdzinska

  • Piotr Pedzisz

  • Elzbieta Patkowska

  • Ewa Lech-Maranda

  • Wojciech Mlynarski

  • Jakub Golab

  • Malgorzata Firczuk

Medical Centers

  • Department of Immunology,Medical University of Warsaw,Warsaw,Poland;Postgraduate School of Molecular Medicine,Warsaw,Poland

  • Department of Pediatrics, Oncology, Haematology & Diabetolog, Medical University of Lodz, lodz, Poland

  • Dept. of Immunology, Medical University of Warsaw, Warsaw, Poland

  • Newcastle Cancer Centre at the Northern Institute for Cancer Research, Newcastle University, Newcastle, United Kingdom

  • Department of Immunology, Transplantology and Internal Diseases Medical University of Warsaw Warsaw Poland

  • Department of Orthopaedics and Traumatology,Medical University of Warsaw,Warsaw,Poland

  • Institute of Hematology and Transfusion Medicine, Warsaw, Poland

Locations

  • Poland

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Acute lymphoblastic leukemia

  • B-cell acute lymphoblastic leukemia

Biomarkers

  • N/A

Drug/Treatment

  • thioredoxin

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved